These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 16603278
21. [Vaccination against human papillomavirus for the prevention of cervical cancer]. Quint WG, ter Harmsel WA, van Doorn LJ. Ned Tijdschr Geneeskd; 2006 Jun 24; 150(25):1380-4. PubMed ID: 16841585 [Abstract] [Full Text] [Related]
22. Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease. Dasbach EJ, Elbasha EH, Insinga RP. Epidemiol Rev; 2006 Jun 24; 28():88-100. PubMed ID: 16740585 [Abstract] [Full Text] [Related]
23. Concordance of human papillomavirus (HPV) type between sex partners: implications for effective utilization of an HPV vaccine. Panther LA. Clin Infect Dis; 2005 Sep 01; 41(5):621-2. PubMed ID: 16080083 [No Abstract] [Full Text] [Related]
24. Human papillomavirus vaccine acceptability among young adult men. Gerend MA, Barley J. Sex Transm Dis; 2009 Jan 01; 36(1):58-62. PubMed ID: 18830138 [Abstract] [Full Text] [Related]
25. Epidemiology and natural history of genital human papillomavirus infection. Weaver BA. J Am Osteopath Assoc; 2006 Mar 01; 106(3 Suppl 1):S2-8. PubMed ID: 16729554 [Abstract] [Full Text] [Related]
26. Prevention strategies of cervical cancer in the HPV vaccine era. Bosch X, Harper D. Gynecol Oncol; 2006 Oct 01; 103(1):21-4. PubMed ID: 16919714 [No Abstract] [Full Text] [Related]
30. Decreasing risk: impact of HPV vaccination on outcomes. Hymel PA. Am J Manag Care; 2006 Dec 01; 12(17 Suppl):S473-83. PubMed ID: 17203991 [Abstract] [Full Text] [Related]
31. [Knowledge of HPV-related genital lesions and of anti-HPV vaccination in a sample of women of north-eastern Italy]. Sopracordevole F, Cigolot F, Lucia E, Marchesoni D. Minerva Ginecol; 2009 Apr 01; 61(2):81-7. PubMed ID: 19255555 [Abstract] [Full Text] [Related]
32. Immunobiology of human papillomavirus infection and vaccination - implications for second generation vaccines. Stanley M, Gissmann L, Nardelli-Haefliger D. Vaccine; 2008 Aug 19; 26 Suppl 10():K62-7. PubMed ID: 18847558 [Abstract] [Full Text] [Related]
33. Lessons from the failure of human papillomavirus vaccine state requirements. Schwartz JL, Caplan AL, Faden RR, Sugarman J. Clin Pharmacol Ther; 2007 Dec 19; 82(6):760-3. PubMed ID: 17971822 [Abstract] [Full Text] [Related]
35. Preparing for HPV vaccination in South Africa: key challenges and opinions. Harries J, Moodley J, Barone MA, Mall S, Sinanovic E. Vaccine; 2009 Jan 01; 27(1):38-44. PubMed ID: 18977271 [Abstract] [Full Text] [Related]
36. Fostering acceptance of human papillomavirus vaccines. Dekker AH. J Am Osteopath Assoc; 2006 Mar 01; 106(3 Suppl 1):S14-8. PubMed ID: 16729556 [Abstract] [Full Text] [Related]
37. [Advisory report from the Health Council of the Netherlands to include human papillomavirus vaccination in the national immunisation programme for the prevention of cervical cancer]. Boeke AJ. Ned Tijdschr Geneeskd; 2008 Apr 26; 152(17):981-3. PubMed ID: 18549170 [Abstract] [Full Text] [Related]
38. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control]. Bégué P, Henrion R, Blanc B, Girard M, Sancho-Garnier H. Bull Acad Natl Med; 2007 Dec 26; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976 [Abstract] [Full Text] [Related]
39. Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer. Wheeler CM. Obstet Gynecol Clin North Am; 2008 Dec 26; 35(4):519-36; vii. PubMed ID: 19061814 [Abstract] [Full Text] [Related]
40. Hear all about it: nightly television news coverage of cervical cancer vaccination in the United States. Wallace LS, Ache KA. J Low Genit Tract Dis; 2009 Jul 26; 13(3):154-8. PubMed ID: 19550212 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]